Antiemesis

David S. Ettinger, Debra K. Armstrong, Sally Barbour, Michael J. Berger, Philip J. Bierman, Bob Bradbury, Georgianna Ellis, Steve Kirkegaard, Dwight D. Kloth, Mark G. Kris, Dean Lim, Laura Boehnke Michaud, Lida Nabati, Kim Noonan, Hope S. Rugo, Darby Siler, Steven M. Sorscher, Sundae Stelts, Lisa Stucky-Marshall, Barbara TodaroSusan G. Urba

Research output: Contribution to journalReview article

44 Scopus citations
Original languageEnglish (US)
Pages (from-to)456-485
Number of pages30
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume10
Issue number4
DOIs
StatePublished - Apr 1 2012

Keywords

  • 5-HT3-receptor antagonists
  • Antiemesis
  • Chemotherapy-induced
  • NCCN clinical practice guidelines
  • NCCN guidelines
  • NK-1 receptor antagonists
  • Nausea and vomiting

ASJC Scopus subject areas

  • Oncology

Cite this

Ettinger, D. S., Armstrong, D. K., Barbour, S., Berger, M. J., Bierman, P. J., Bradbury, B., Ellis, G., Kirkegaard, S., Kloth, D. D., Kris, M. G., Lim, D., Michaud, L. B., Nabati, L., Noonan, K., Rugo, H. S., Siler, D., Sorscher, S. M., Stelts, S., Stucky-Marshall, L., ... Urba, S. G. (2012). Antiemesis. JNCCN Journal of the National Comprehensive Cancer Network, 10(4), 456-485. https://doi.org/10.6004/jnccn.2012.0047